Pharming Statistics Share Statistics Pharming has 68.51M
shares outstanding. The number of shares has increased by 0.29%
in one year.
Shares Outstanding 68.51M Shares Change (YoY) 0.29% Shares Change (QoQ) 0.29% Owned by Institutions (%) 0.01% Shares Floating 67.07M Failed to Deliver (FTD) Shares 18 FTD / Avg. Volume 0.35%
Short Selling Information The latest short interest is 1.1K, so 0% of the outstanding
shares have been sold short.
Short Interest 1.1K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -62.97 and the forward
PE ratio is 161.31.
Pharming's PEG ratio is
-10.14.
PE Ratio -62.97 Forward PE 161.31 PS Ratio 2.26 Forward PS 2.3 PB Ratio 3.03 P/FCF Ratio -258.67 PEG Ratio -10.14
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Pharming.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.77,
with a Debt / Equity ratio of 0.49.
Current Ratio 3.77 Quick Ratio 3.02 Debt / Equity 0.49 Debt / EBITDA 6.65 Debt / FCF -41.84 Interest Coverage -0.99
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $735.64K Profits Per Employee $-26.35K Employee Count 404 Asset Turnover 0.74 Inventory Turnover 0.64
Taxes Income Tax 2.43M Effective Tax Rate -29.61%
Stock Price Statistics The stock price has increased by 58.66% in the
last 52 weeks. The beta is 0.54, so Pharming's
price volatility has been higher than the market average.
Beta 0.54 52-Week Price Change 58.66% 50-Day Moving Average 10.87 200-Day Moving Average 9.32 Relative Strength Index (RSI) 72.67 Average Volume (20 Days) 5,146
Income Statement In the last 12 months, Pharming had revenue of 297.2M
and earned -10.64M
in profits. Earnings per share was -0.15.
Revenue 297.2M Gross Profit 261.8M Operating Income -8.62M Net Income -10.64M EBITDA 16.32M EBIT 245K Earnings Per Share (EPS) -0.15
Full Income Statement Balance Sheet The company has 54.94M in cash and 108.42M in
debt, giving a net cash position of -53.47M.
Cash & Cash Equivalents 54.94M Total Debt 108.42M Net Cash -53.47M Retained Earnings -275.49M Total Assets 446.26M Working Capital 157.83M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.79M
and capital expenditures -796K, giving a free cash flow of -2.59M.
Operating Cash Flow -1.79M Capital Expenditures -796K Free Cash Flow -2.59M FCF Per Share -0.04
Full Cash Flow Statement Margins Gross margin is 88.09%, with operating and profit margins of -2.9% and -3.58%.
Gross Margin 88.09% Operating Margin -2.9% Pretax Margin -2.76% Profit Margin -3.58% EBITDA Margin 5.49% EBIT Margin -2.9% FCF Margin -0.87%
